Cargando…

A67 Bloodstream infections by carbapenem-resistant Klebsiella pneumoniae subsp. pneumoniae: Bayesian phylogenetic analysis of whole genomes

Bloodstream infection (BSI) caused by carbapenemase-producing Enterobacteriaceae (CPE) is a major public health concern, particularly in the hospital setting. The rapid detection of resistance patterns is of paramount importance for establishing the proper antibiotic regime. In addition, in countrie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cella, Eleonora, Leoni, Davide, Mirandola, Walter, Fontana, Carla, Sarmati, Loredana, Andreoni, Massimo, Angeletti, Silvia, Ciccozzi, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstract Overview
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735889/ http://dx.doi.org/10.1093/ve/vez002.066

Ejemplares similares

A66 Multi-drug-resistant Klebsiella pneumoniae strains circulating in hospital setting: Whole-genome sequencing and Bayesian phylogenetic analysis for outbreak investigations
por: Cella, E, et al.
Publicado: (2018)

Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae subsp. pneumoniae Isolates in a Tertiary Italian Hospital: Identification of a New Mutation of the Carbapenemase Type 3 (KPC-3) Gene Conferring Ceftazidime/Avibactam Resistance
por: Fontana, Carla, et al.
Publicado: (2021)

Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections and Outcomes
por: Yuan, Youhua, et al.
Publicado: (2020)

Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2021)

Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study
por: Campogiani, Laura, et al.
Publicado: (2023)

Emergence of KPC-producing Klebsiella pneumoniae in Italy
por: Fontana, Carla, et al.
Publicado: (2010)

Multi-drug resistant Klebsiella pneumoniae strains circulating in hospital setting: whole-genome sequencing and Bayesian phylogenetic analysis for outbreak investigations
por: Cella, Eleonora, et al.
Publicado: (2017)

Outcomes and Risk Factors of Bloodstream Infections Caused by Carbapenem-Resistant and Non-Carbapenem-Resistant Klebsiella pneumoniae in China
por: Liang, Xiaoxue, et al.
Publicado: (2022)

Early use of polymyxin B reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
por: Liang, Qiqiang, et al.
Publicado: (2019)

Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae
por: Yu, Zhenwei, et al.
Publicado: (2022)

Fatal Donor-Derived Carbapenem-Resistant Klebsiella pneumoniae Infection in a Combined Kidney-Pancreas Transplantation
por: Varotti, Giovanni, et al.
Publicado: (2016)

Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection
por: Wang, Zhe, et al.
Publicado: (2018)

Molecular characterization of carbapenem-resistant and virulent plasmids in Klebsiella pneumoniae from patients with bloodstream infections in China
por: Yang, Yongqiang, et al.
Publicado: (2021)

Preliminary exploration on the serum biomarkers of bloodstream infection with carbapenem‐resistant Klebsiella pneumoniae based on mass spectrometry
por: Bao, Jinfeng, et al.
Publicado: (2021)

Risk Factors for Mortality and Outcomes in Hematological Malignancy Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
por: Meng, Haiyang, et al.
Publicado: (2022)

Clinical and Molecular Characterizations of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infection in a Chinese Hospital
por: Zhang, Na, et al.
Publicado: (2022)

A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
por: Luterbach, Courtney L., et al.
Publicado: (2022)

Draft Genome Sequence of Klebsiella pneumoniae subsp. pneumoniae ATCC 9621
por: Poehlein, Anja, et al.
Publicado: (2017)

Clinical characteristics, risk factors and outcomes of Klebsiella pneumoniae pneumonia developing secondary Klebsiella pneumoniae bloodstream infection
por: Chen, Juan, et al.
Publicado: (2023)

Emerging high-risk ST101 and ST307 carbapenem-resistant Klebsiella pneumoniae clones from bloodstream infections in Southern Italy
por: Loconsole, Daniela, et al.
Publicado: (2020)

Limiting and controlling carbapenem-resistant Klebsiella pneumoniae
por: Saidel-Odes, Lisa, et al.
Publicado: (2013)

No Carbapenem Resistance in Pneumonia Caused by Klebsiella Species
por: Yayan, Josef, et al.
Publicado: (2015)

Epidemiological Study of Carbapenem-resistant Klebsiella Pneumoniae
por: Lin, Di, et al.
Publicado: (2018)

Phylogenetic Analysis of Multi-Drug Resistant Klebsiella pneumoniae Strains From Duodenoscope Biofilm: Microbiological Surveillance and Reprocessing Improvements for Infection Prevention
por: Ciccozzi, Massimo, et al.
Publicado: (2019)

Risk Factors for Subsequential Carbapenem-Resistant Klebsiella pneumoniae Clinical Infection Among Rectal Carriers with Carbapenem-Resistant Klebsiella pneumoniae
por: Chen, Xia, et al.
Publicado: (2020)

Epidemiology of bloodstream infections sustained by carbapenem-resistant Klebsiella pneumonia in a large teaching hospital in northern Italy
por: Alicino, C, et al.
Publicado: (2015)

Epidemiology of Klebsiella pneumoniae bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality
por: Tian, Lijun, et al.
Publicado: (2016)

Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies
por: Zhang, Piaopiao, et al.
Publicado: (2020)

Derivation of a Model to Guide Empiric Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection in an Endemic Area
por: Weston, Gregory, et al.
Publicado: (2020)

Distribution of fluoroquinolone resistance determinants in Carbapenem-resistant Klebsiella pneumoniae clinical isolates associated with bloodstream infections in China
por: Zhan, Qing, et al.
Publicado: (2021)

Risk Factors of 30-Day All-Cause Mortality in Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection
por: Liu, Keh-Sen, et al.
Publicado: (2021)

Cost-effectiveness analysis of ceftazidime-avibactam as definitive treatment for treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
por: Kong, Wenqiang, et al.
Publicado: (2023)

Prevalence of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae and Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae in China Determined via Mouse Lethality Tests
por: Hu, Dakang, et al.
Publicado: (2022)

Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study
por: Sun, Xiangyuan, et al.
Publicado: (2023)

Mortality markers in nosocomial Klebsiella pneumoniae bloodstream infection
por: Durdu, Bulent, et al.
Publicado: (2016)

Rapid Nanopore Assay for Carbapenem-Resistant Klebsiella pneumoniae
por: Niu, Haofu, et al.
Publicado: (2019)

Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae
por: Mulroney, K. T., et al.
Publicado: (2017)

The Metabolome of Carbapenem-Resistant Klebsiella pneumoniae Infection in Plasma
por: Wen, Zhongwei, et al.
Publicado: (2021)

Carbapenem-Resistant Klebsiella pneumoniae Associated with COVID-19
por: Dumitru, Irina Magdalena, et al.
Publicado: (2021)

Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains
por: Zhang, Feiyang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m1a6jjctmgj2m9ug7l8qoj7u02